Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US DoJ Memos May Hint At Enforcement Stepdown

Executive Summary

The US Department of Justice has ordered its attorneys to ask for the dismissal of more whistleblower cases, and to avoid basing civil enforcement actions solely on guidance documents. Both could lead to fewer enforcement actions against device manufacturers.

You may also be interested in...



Enforcement Experts: COVID-19 Backlog Could Last Years

The US Department of Justice faces significant challenges in investigating and punishing bad behavior during the COVID-19 pandemic, attorneys say.

New AG William Barr May Bring A Lighter Touch On FCA Enforcement

During his January confirmation hearing, new Attorney General William Barr promised to uphold the False Claims Act. But his past statements condemning the law have some wondering how vigorous that enforcement will be.

Mid-Year Enforcement Roundup: Focus On Opioids, As Other Areas Lag

A recent report from law firm Gibson Dunn seems to show that the Trump administration, while aggressively pursuing opioid enforcement actions, slowed down enforcement in other areas during the first half of 2018. But important case-law developments continue.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT122168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel